Inactive Instrument

Compass Biotechnologies, Inc. Stock price Other OTC

Equities

US20452Q1031

Pharmaceuticals

Sales 2018 - Sales 2019 - Capitalization 158K
Net income 2018 - Net income 2019 - EV / Sales 2018 -
Net Debt 2018 516K Net Debt 2019 480K EV / Sales 2019 -
P/E ratio 2018
-2.59 x
P/E ratio 2019
-3.95 x
Employees -
Yield 2018 *
-
Yield 2019
-
Free-Float 99%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 20-04-17
Sales & Marketing - 19-07-21
Members of the board TitleAgeSince
Chief Executive Officer - 20-04-17
More insiders
Bangi Inc. is focused on the acquisition, ownership and management of properties leased to experienced, state-licensed operators for regulated use of Cannabis facilities. The Company intends to acquire properties through sale-leaseback transactions and third-party purchases.
More about the company
  1. Stock
  2. Equities
  3. Stock Bangi Inc.
  4. Stock Compass Biotechnologies, Inc. - Other OTC